Skip Navigation



Japanese Journal of Clinical Oncology Advance Access published online on May 7, 2007

Japanese Journal of Clinical Oncology, doi:10.1093/jjco/hym021
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
37/4/250    most recent
hym021v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Usami, S.
Right arrow Articles by Ohuchi, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Usami, S.
Right arrow Articles by Ohuchi, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 Foundation for Promotion of Cancer Research

Reliability of Prognostic Factors in Breast Carcinoma Determined by Core Needle Biopsy

Shin Usami1,2, Takuya Moriya1,, Masakazu Amari2, Akihiko Suzuki2, Takanori Ishida2, Hironobu Sasano1 and Noriaki Ohuchi2

1 Department of Pathology
2 Breast and Endocrine Surgery, Tohoku University Hospital, Sendai, Japan

For reprints and all correspondence: Takuya Moriya, Department of Pathology, Tohoku University Hospital. 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan. E-mail: moriya{at}patholo2.med.tohoku.ac.jp

Received October 17, 2006; accepted November 22, 2006

Objective: The aim of this study was to evaluate the reliability of information obtained by core needle biopsy (CNB).

Methods: We studied 111 women (112 lesions) with breast cancer who underwent CNB and subsequent surgical excision. Six factors (histological type, nuclear grade, histological grade, estrogen receptor (ER) status, progesterone receptor (PR) status, and human epidermal growth factor receptor-2 (HER2) status) were evaluated in a blinded fashion at CNB and at surgical excision.

Results: The histological type at CNB correlated exactly with that of the excisional specimen in 83% (87/105) of the cases. Of the 45 in situ lesions at CNB, 16 (36%) were found to have invasive carcinoma at surgical excision. The difference between the specimens from CNB and those from surgery in terms of the absolute concordance rate and {kappa} statistic value were 61% with a fair {kappa} value (0.26) in the nuclear grade, 75% with a moderate {kappa} value (0.55) in the histological grade, 95% with an almost perfect {kappa} value (0.84) in ER, 88% with a substantial {kappa} value (0.70) in PR and 88% with a substantial {kappa} value (0.65) in HER2. Regarding the evaluation of nuclear and histological grades, a trend toward greater accuracy was observed when thicker specimens were used.

Conclusions: CNB provided reliable information on the histological type of invasive carcinoma. It also evaluated ER, PR and HER2 (only in cases where the score was 3+) accurately in spite of the limited quantity of the specimen obtained with the thin (16-gauge) needle.

Key Words: breast cancer • core needle biopsy • HER2 • hormone receptor • prognostic factor


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
E A Rakha and I O Ellis
An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens
J. Clin. Pathol., December 1, 2007; 60(12): 1300 - 1306.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.